Lombaard J, Ssali F, Thanyawee P, Fourie J, et al. Long-term safety, tolerability and antiviral activity of rilpivirine in antiretroviral-naive adolescents living with HIV-1, aged 12 to less than 18 years: Week 240 findings of a phase 2, open-label study, PAINT. Antimicrob Agents Chemother 2021 Dec 6:AAC0091621. doi: 10.1128/AAC.00916.
PMID: 34871089